A Redwood City gene therapy company is cutting 78 jobs as it jump-starts a program to treat a common cause of blindness


The company is restructuring to refocus its efforts on wet age-related macular degeneration, or wet AMD.

Previous Cleveland Fed's top official in Pittsburgh is leaving
Next Craft & Crew Hospitality and Finnegans team up on bone broth 'brew' for dogs